Examples of 'competitive inhibitors' in a sentence
Meaning of "competitive inhibitors"
In the context of biochemistry and pharmacology, competitive inhibitors are substances that bind to the active site of an enzyme or receptor, preventing the binding of the natural substrate and reducing the enzymatic or receptor activity
How to use "competitive inhibitors" in a sentence
Basic
Advanced
competitive inhibitors
Competitive inhibitors bind at the active site.
Sulfa drugs also act as competitive inhibitors.
Competitive inhibitors of polyamine synthesis had nonspecific effects.
Many drugs are competitive inhibitors of enzymes.
Competitive inhibitors are often similar in structure to the real ligand.
Now some of them are competitive inhibitors.
Competitive inhibitors are inhibitors that only target free enzyme molecules.
Examples of reversible competitive inhibitors include boronic acids.
This is the case for antibodies and for competitive inhibitors.
They are weak competitive inhibitors of phosphodiesterase.
Current approaches to neutralising chemoresistance have centred on developing competitive inhibitors.
Substrate analogs can act as competitive inhibitors of an enzymatic reaction.
Often competitive inhibitors strongly resemble the real substrate of the enzyme.
All of these latter peptides were competitive inhibitors of the cyclization reaction.
Such assays can be used to identify inhibitors that are directly competitive inhibitors.
See also
Also contemplated as useful methionine competitive inhibitors are cycloleucine and halogenated methionines.
Benzyloxyamine and benzylhydrazine are phenethylamine derivatives which apparently act as competitive inhibitors.
Presents findings on various competitive inhibitors of the firefly luciferase luminescent reaction.
Another class of antibacterial agents is compounds that function as competitive inhibitors of bacterial enzymes.
Competitive inhibitors are often similar in structure to the real substrate see examples below.
Irreversible inhibitors are similar to competitive inhibitors as they both bind to the active site.
Most competitive inhibitors function by binding reversibly to the active site of the enzyme.
Both effectors appeared to be competitive inhibitors with regard to ADP.
Competitive inhibitors usually have structural similarities to the substrates and or ES complex.
Only a few true FMO competitive inhibitors have been reported.
Such mTOR inhibitors include rapamycin analogs and ATP competitive inhibitors.
Various competitive inhibitors of PARP have been described.
Further exemplary NGF inhibitory compounds are compounds that are competitive inhibitors of NGF.
Competitive inhibitors of PARP are known.
The corresponding triphosphates function as competitive inhibitors or alternative substrates for viral RT.
The improved competitive inhibitors of FAAH display enhanced activity over conventional competitive inhibitors of FAAH.
Small peptide agents can serve as competitive inhibitors of PSCA protein assembly.
Competitive Inhibitors cause KM to increase and Vmax to remain the same.
These analogs act as competitive inhibitors of NOS.
Alternatively, alkoxylipids or hydrocarbons have been shown to be competitive inhibitors.
Classes of CDK ATP competitive inhibitors and the most representative compound of each category.
Such peptide-based inhibitors are competitive inhibitors.
Anti-estrogens are competitive inhibitors of estrogen receptors.
Competitive inhibitors of TNF-a have been shown to be useful in other applications as well.
In further embodiments, reversible competitive inhibitors may be employed.
Phytocystatins are competitive inhibitors of cysteine proteases in plants, principally inhibiting papain-like proteases activity.
Process as claimed in claim 9, wherein the competitive inhibitors are lithium ions.
Sulfonamides are competitive inhibitors of the incorporation of p-aminobenzoic acid.
In one embodiment, the compounds of the invention may be competitive inhibitors of mTOR.
The term includes competitive inhibitors as well as non-competitive inhibitors.
Therefore, the phosphotyrosine mimic-containing compounds are competitive inhibitors of that binding.
Ligands known to be competitive inhibitors of the aVB3 receptor are used therefor.
As a result, many sources state that this is the defining feature of competitive inhibitors.
Additionally, both compounds are competitive inhibitors of one another, suggesting overlapping interaction sites.
Atorvastatin and pharmaceutically acceptable salts thereof are selective, competitive inhibitors of HMG-CoA reductase.
You'll also be interested in:
Examples of using Inhibitors
Show more
It is not uncommon to have inhibitors placed in a clone
Inhibitors add challenges to the treatment of hemophilia
Neurotoxins and enzyme inhibitors associated with
Examples of using Competitive
Show more
They get really competitive about it too
Competitive in terms of both price and technology
Your mistake was getting competitive with a machine
